SCHEMBL4292851

SCHEMBL4292851

CSCCC1NC2(CCN(C(=O)c3ccno3)CC2)[N]C1=O

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNA4 P43681 2/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRM2 P08172 1/20 0.37
NAMPT P43490 1/20 0.37
PARP1 P09874 1/20 0.34
NOS2 P35228 1/20 0.33
MMP1 P03956 1/20 0.32
MMP3 P08254 1/20 0.32
DGAT1 O75907 1/20 0.31
CACNA1G O43497 1/20 0.31
JAK1 P23458 1/20 0.31
PIK3CA P42336 1/20 0.31
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3997310 0.82 CHRNA4 (0.41) CHRNA4CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL5666002 0.80 TSHR (0.43)
SCHEMBL2942901 0.79 CHRNA4 (0.39) CHRNA4CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL4003441 0.78 HPGD (0.44)
SCHEMBL3998893 0.78 HRH3 (0.48)
SCHEMBL5666116 0.78 HDAC8 (0.35) CHRNA4CHRNB2CHRNA3NAMPTNOS2
SCHEMBL1801988 0.77 CHRNA4 (0.36) CHRNA4CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL3997851 0.77 ATM (0.43)
SCHEMBL4000579 0.76 CYP3A4 (0.36) NAMPTJAK1
SCHEMBL5666327 0.75 HDAC8 (0.33) NAMPTNOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO disclosed
EP-1730147-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2006-12-13 EP disclosed
WO-2005095402-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2005-10-13 WO disclosed